Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial
BMJ, 2010-07, Vol.341 (7766), p.239-239 [Peer Reviewed Journal]The FUTURE I/II Study Group 2010 ;2010 BMJ Publishing Group Ltd ;Copyright: 2010 © The FUTURE I/II Study Group 2010 ;The FUTURE I/II Study Group 2010 2010 The FUTURE I/II Study Group ;ISSN: 0959-8138 ;ISSN: 0959-8146 ;ISSN: 1756-1833 ;EISSN: 1468-5833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.c3493 ;PMID: 20647284 ;CODEN: BMJOAE
Full text available